EEG Spectral Pattern of Deep Sedation-induced Airway Adverse Effects

November 2, 2022 updated by: National Taiwan University Hospital

Associations Between Breath Sound Frequency Pattern, Capnography and Electroencephalographic Density Spectrum Array During Deep Sedation in High Risk Patients.

To investigate the associations bewteen the sedation level and the airway adverse effects by using the EEG, Airmod breath sound monitor and the capnography.

Study Overview

Status

Recruiting

Conditions

Detailed Description

Deep sedation is mandatory for many invasive procedures such as the digestive endoscopy, bronchoscopy and cystoscopy. However, deep sedation may induce respiratory adverse effects including airway obstruction, hypoventilation and apnea. These respiratory adverse effects, which may occur in more than 20% of high-risk groups (eg, children, the elderly, and patients with sleep apnea), hence, are the major concerns of the anesthetic care. However, It is difficult for clinicians to objectively quantify the sedation level and find the associations of inadequate sedation level and the occurrence of respiratory adverse effects.

Airway obstruction and respiratory rate decline during deep sedation are conventionally monitored by using capnography(EtCO2 waveform). However, previous studies have tracheal breath sound monitoring can achieve better detection accuracy than the capnography. The novel Airmod smart breathing monitor has the functions of breath sound recording, anti-noise signal processing, event recording and respiratory rate analysis and research. Through the continuous breath sound recording, airway adverse effects during sedation may be detected, and these breathing spectrogram can be presented for image analysis. This is helpful for researcher to identify associations between airway adverse effect and the sedation level.

The state-of-art anesthetic depth is determined by using the electroencephalogram (EEG). Both EEG raw data or the EEG spectrogram graphs may be used for quantify the sedation level with respiratory adverse effects. Accordingly, this study aims to investigate the associations between the sedation level and the airway adverse effects by using the EEG monitor, Airmod breath sound monitor and the capnography.

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Chun-Yu Wu
  • Phone Number: 886-2-23562158

Study Locations

      • Taipei, Taiwan
        • Recruiting
        • National Taiwan University Hospital
        • Contact:
          • Chun-Yu Wu
          • Phone Number: 886-2-23562158

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Two patient groups of higher risk for invasive procedural sedation will be investigated, namely the pediatric patients and geriatric patients.

Description

Inclusion Criteria:

Patients undergoing procedural sedation with expected produre time longer than 30 minutes

  • Pediatric group: age 4-8 year-old
  • Geriatric group: age>= 65 year-old

Exclusion Criteria:

  • Preoperative active brain conditions (dementia, Parkinsonism, seizure)
  • A history of nasal or oral tumor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Geriatric population
patient with ages above 65-yr
Respiratory monitoring and sedation depth monitoring will be applied during procedural sedation.
Other Names:
  • Electroencephalographic monitoring
  • Capnographic monitoring
Pediatric population
patient with ages between 4-8 year old
Respiratory monitoring and sedation depth monitoring will be applied during procedural sedation.
Other Names:
  • Electroencephalographic monitoring
  • Capnographic monitoring

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurence of airway obstruction during sedation
Time Frame: 0.5-2 hours
Airway obstruction detected by the breath sound monitor or capnography
0.5-2 hours
Occurence of apnea event during sedation
Time Frame: 0.5-2 hours
Apnea detected by the breath sound monitor or capnography
0.5-2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2022

Primary Completion (Anticipated)

October 1, 2023

Study Completion (Anticipated)

October 1, 2023

Study Registration Dates

First Submitted

October 23, 2022

First Submitted That Met QC Criteria

October 23, 2022

First Posted (Actual)

October 27, 2022

Study Record Updates

Last Update Posted (Actual)

November 4, 2022

Last Update Submitted That Met QC Criteria

November 2, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 202209055DINB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

The IPD can be obtained by contacting the corresponding author after the study is published

IPD Sharing Time Frame

The data will be availabel after publication.

IPD Sharing Access Criteria

For research purpose only. The IPD will not be provided for commercial purpose.

IPD Sharing Supporting Information Type

  • Clinical Study Report (CSR)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Procedural Sedation

Clinical Trials on Airmod breathing sound monitoring

3
Subscribe